Oncology Information Systems Market: Market Size & Forecast 2026

Oncology information systems encompass a range of software solutions designed to support cancer care delivery, including radiation oncology systems, oncology-specific EHR modules, practice management tools, tumor registries, and clinical decision support applications. The global market was valued at approximately $3.2 billion in 2025, with multiple independent research firms converging on this figure through vendor revenue modeling rather than direct government statistical reporting.

• •Market estimates are derived from private research firms using vendor revenue triangulation, as no government or official statistical agency publishes direct market figures for this IT sector.
• •Projected market size by 2030 ranges from approximately $4.69 billion to $4.80 billion across major research estimates.
• •The U.S. market alone is estimated at roughly 30.6% of global share, valued at approximately $1 billion with a 7.4% projected CAGR through 2030.

Rising global cancer prevalence is a foundational growth driver, with aging populations and lifestyle-related factors contributing to increasing patient volumes that strain existing clinical workflows and necessitate more sophisticated management tools. Regulatory and reimbursement pressures compel healthcare providers to adopt structured documentation and reporting systems that oncology information platforms provide.

• •Growing cancer incidence worldwide increases demand for systems that streamline complex, multi-disciplinary treatment coordination across surgery, radiation, and medical oncology teams.
• •Government mandates for cancer registry reporting, quality measurement programs, and health information exchange interoperability require institutions to implement compliant IT infrastructure.
• •Advances in precision medicine, genomics, and targeted therapies generate larger volumes of patient-specific data that oncology systems must capture, manage, and analyze for clinical decision support.

The market is commonly segmented by product type into professional services, software, and hardware components, with software solutions representing the largest and fastest-growing category driven by cloud migration and platform integration trends. Geographically, North America dominates due to advanced healthcare IT infrastructure, favorable reimbursement environments, and high rates of cancer center consolidation, while Europe and Asia-Pacific represent significant and growing secondary markets.

• •The United States accounts for approximately 30.6% of the global oncology information systems market, making it the single largest country market.
• •North America leads globally, with the U.S. segment projected to grow at 7.4% CAGR through 2030.
• •Emerging markets in Asia-Pacific, Latin America, and the Middle East are expected to gain share as healthcare digitization accelerates and cancer care access expands.

What are the recent trends and outlook?

Cloud-native delivery models are accelerating adoption, particularly among community cancer centers seeking to reduce IT infrastructure costs and improve scalability compared to legacy on-premise deployments. Artificial intelligence and machine learning are increasingly embedded into oncology information systems for radiation plan optimization, treatment response prediction, and automated clinical documentation, creating differentiated product capabilities.

• •AI and machine learning integration is emerging as a key product differentiator, with applications in radiation dose calculation, image segmentation, treatment planning automation, and predictive analytics for clinical outcomes.
• •Consolidation among cancer treatment providers drives demand for interoperable, enterprise-scale oncology platforms that unify disparate departmental systems across multi-site networks.
• •Value-based care models and outcomes-based reimbursement are increasing demand for systems capable of capturing, analyzing, and reporting comprehensive quality metrics and real-world evidence at the patient and population level.